{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:42:45Z","timestamp":1759178565878},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.eimc.2015.10.012","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T17:38:00Z","timestamp":1449250680000},"page":"477-483","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluaci\u00f3n de la capacidad de difusi\u00f3n tisular de antibi\u00f3ticos en isquemia de miembros inferiores"],"prefix":"10.1016","volume":"34","author":[{"given":"Silvia","family":"Lozano-Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Patricio","family":"Linares-Palomino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Vera-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Bravo-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Quero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Ros-D\u00ede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.10.012_bib0150","first-page":"81","article-title":"Inter-society consensus for the management of peripheral arterial disease","volume":"26","author":"Norgren","year":"2007","journal-title":"Int Angiol."},{"key":"10.1016\/j.eimc.2015.10.012_bib0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.apmr.2004.06.072","article-title":"Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations","volume":"86","author":"Dillingham","year":"2005","journal-title":"Arch Phys Med Rehabil."},{"key":"10.1016\/j.eimc.2015.10.012_bib0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia."},{"key":"10.1016\/j.eimc.2015.10.012_bib0165","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/516148","article-title":"Osteomyelitis of the foot in diabetic patients","volume":"25","author":"Lipsky","year":"1997","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.10.012_bib0170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1056-8727(99)00065-3","article-title":"Deep foot infections in patients with diabetes and foot ulcer: An entity with different characteristics, treatments, and prognosis","volume":"13","author":"Eneroth","year":"1999","journal-title":"J Diabetes Complications."},{"key":"10.1016\/j.eimc.2015.10.012_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.10.012_bib0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis346","article-title":"Infectious Diseases Society of America Clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.10.012_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dmrr.2248","article-title":"Expert opinion on the management of infections in the diabetic foot","volume":"28","author":"Lipsky","year":"2012","journal-title":"Diabetes Metab Res Rev."},{"key":"10.1016\/j.eimc.2015.10.012_bib0190","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/dc13-2510","article-title":"Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: Have we answered the question","volume":"37","author":"Lipsky","year":"2014","journal-title":"Diabetes Care."},{"key":"10.1016\/j.eimc.2015.10.012_bib0195","first-page":"208","article-title":"Management of peripheral arterial disease (PAD)","volume":"19","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.eimc.2015.10.012_bib0200","first-page":"43","article-title":"Transcutaneous Oximetry in Clinical Practice: Consensus statements from an expert panel based on evidence","volume":"36","author":"Fife","year":"2009","journal-title":"Undersea Hyperb Med."},{"key":"10.1016\/j.eimc.2015.10.012_bib0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejvs.2011.12.004","article-title":"The use of transcutaneous oximetry to predict healing complications of lower limb amputations: A systematic review and meta-analysis","volume":"43","author":"Arsenault","year":"2012","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"10.1016\/j.eimc.2015.10.012_bib0210","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous determination of 12 \u03b2-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: Application to therapeutic drug monitoring antimicrob","volume":"55","author":"Verdier","year":"2011","journal-title":"Agents Chemother."},{"key":"10.1016\/j.eimc.2015.10.012_bib0215","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/FTD.0b013e318297b6b0","article-title":"Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers","volume":"35","author":"Helmy","year":"2013","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.eimc.2015.10.012_bib0220","first-page":"783","article-title":"Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector Biomed","volume":"19","author":"Cho","year":"2005","journal-title":"Chromatogr."},{"key":"10.1016\/j.eimc.2015.10.012_bib0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jchromb.2014.08.002","article-title":"Determination of the free and total concentrations of vancomycin by two-dimensional liquid chromatography and its application in elderly patients","volume":"969","author":"Li","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.eimc.2015.10.012_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron."},{"key":"10.1016\/j.eimc.2015.10.012_bib0235","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015 [consultado 22 Jun 2015]. Disponible en: http:\/\/www.eucast.org"},{"key":"10.1016\/j.eimc.2015.10.012_bib0240","series-title":"Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Fifth Informational Supplement. CLSI document M100-S25","year":"2015"},{"key":"10.1016\/j.eimc.2015.10.012_bib0245","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.avsg.2010.12.025","article-title":"The ankle-brachial index and the diabetic foot: a troublesome marriage","volume":"25","author":"Aerden","year":"2011","journal-title":"Ann Vasc Surg."},{"key":"10.1016\/j.eimc.2015.10.012_bib0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1464-5491.2001.00460.x","article-title":"The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb","volume":"18","author":"Raymakers","year":"2001","journal-title":"Diabet Med."},{"key":"10.1016\/j.eimc.2015.10.012_bib0255","first-page":"274","article-title":"Is antibiotic penetration compromised in the ischaemic tissues of patients undergoing amputation?","volume":"74","author":"Kerin","year":"1992","journal-title":"Ann R Coll Surg Engl."},{"key":"10.1016\/j.eimc.2015.10.012_bib0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1556\/AMicr.48.2001.1.2","article-title":"Fleroxacin uptake in isquemic limb tissue","volume":"48","author":"Mioglioli","year":"2001","journal-title":"Acta Microbiol Immunol Hung."},{"key":"10.1016\/j.eimc.2015.10.012_bib0265","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.32.9.1320","article-title":"Vancomycin concentrations in infected and noninfected human bone","volume":"32","author":"Graziani","year":"1988","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2015.10.012_bib0270","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00228-008-0531-5","article-title":"Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections","volume":"64","author":"Majcher-Peszynska","year":"2008","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.eimc.2015.10.012_bib0275","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/jcph.296","article-title":"Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection","volume":"54","author":"Eslam","year":"2014","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.eimc.2015.10.012_bib0280","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/jac\/dkh412","article-title":"Tissue and serum levofloxacin concentrations in diabetic foot infection patients","volume":"54","author":"Oberdorfer","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.10.012_bib0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0924-8579(01)00423-X","article-title":"Tissue and serum concentrations of levofloxacin in orthopaedic patients","volume":"18","author":"Baum","year":"2001","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.eimc.2015.10.012_bib0290","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/42.4.543","article-title":"Penetration of ceftazidime into bone from severely ischaemic limbs","volume":"42","author":"Raymakers","year":"1998","journal-title":"J Antimicrob Chemother."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15003845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15003845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T06:20:15Z","timestamp":1537165215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15003845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0213005X15003845"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.10.012","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n de la capacidad de difusi\u00f3n tisular de antibi\u00f3ticos en isquemia de miembros inferiores","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}